API
< Back to all clusters
[HEALTH] · United States · 28 sources

started · updated

American Cancer Society updates prostate cancer screening guidelines

The American Cancer Society (ACS) has issued its first major update to prostate cancer screening guidelines since 2010, shifting from a model of shared decision-making to direct recommendations for regular testing. The new guidance emphasizes the use of the prostate-specific antigen (PSA) blood test to improve early detection and reduce mortality.

For men at average risk, the ACS recommends a PSA test every two years between the ages of 50 and 69. Men at higher risk, including Black men and those with a strong family history of the disease, are advised to begin annual screenings at age 45. For men aged 70 to 74, the decision to continue testing should be made in consultation with a physician, while screening is generally not recommended for those aged 75 and older or those with a life expectancy of less than 10 years.

The update aims to address health disparities and minimize the risks of overtreatment. To reduce unnecessary biopsies for slow-growing tumors, the guidelines suggest that men with elevated PSA levels should undergo repeat testing or an MRI scan to determine if the cancer is clinically significant before proceeding to invasive procedures. This shift follows long-term research indicating that regular screening can significantly decrease the risk of dying from prostate cancer.

Entities

American Cancer Society · CA: A Cancer Journal for Clinicians · Centers for Disease Control and Prevention · National Cancer Institute · Neeraj Agarwal · Robert Smith · William Dahut

Sources